Features
In This Issue: We dive into sustainable practices in the pharma industry and effective ways to safely implement them.
Sustainability principles can be effectively integrated into commissioning and qualification (C&Q) projects to support environmental goals without compromising compliance, quality, or patient safety. By positioning C&Q as both a verification tool and an enabler of sustainable intent, this article outlines a practical path for the pharmaceutical sector to enhance operational efficiency,...
The pharmaceutical industry’s embrace of digital technologies and sustainability is no longer a competitive advantage, but an operational necessity. As Pharma 4.0™ matures, its integration will be vital for achieving net-zero objectives and achieving pharmaceutical excellence.
Crafting a sustainable packaging strategy for the pharmaceutical industry is complex and requires balancing environmental responsibility with regulatory compliance and operational costs. In this article, we explore the key drivers, challenges, and best practices for developing such a strategy.
The development of platform drug delivery devices for combination products offers a transformative approach to drug delivery by enabling the reuse of device data across multiple drug and device combinations.
Oligonucleotide therapies hold great promise for treating a wide range of diseases, including the undruggable, but their journey from lab to patient hinges on fundamental manufacturing challenges that the industry is racing to solve.
Michelle Vuolo is currently Head of Quality at Tulip Interfaces, Inc., a platform developer that enables manufacturers of many industries to build digital content to manage their operations. Before joining Tulip, Michelle spent more than 24 years in the biopharmaceutical and medical devices industries in quality control (QC) laboratories, engineering technical support, quality assurance...
Stephanie Stärkle is a project engineer at VTU Engineering in Switzerland, where she leads engineering projects from concept to execution in GMP-regulated environments including cost estimation, equipment design and specification, deadline management, and coordination with cross-functional stakeholders such as vendors, quality assurance, operations, and qualification. She holds a bachelor’s...
Water and steam are essential in the pharmaceutical industry. Both are used for multiple purposes, including cleaning and sterilizing equipment, laboratory activities, and as an ingredient.
When I began my career as an engineer in a major pharmaceutical company, I worked in an engineering department filled with highly experienced senior engineers. I admired their depth of knowledge and the way they had accumulated a wealth of practical information over decades. Their grasp of systems, processes, and equipment was impressive and humbling. I found myself anxious to build that same...
Advancements in technology—such as process intensification, continuous manufacturing, and 3D printing—are enabling transportable and point-of-care (PoC) medicines manufacturing, especially with the rise of personalized medicine. Modular, small-scale production systems are particularly well-suited for cell and gene therapies and other advanced therapy medicinal products (ATMPs) designed for...
Simplified approaches that enable changes to analytical procedures over their lifecycle are needed to allow continual improvements and adaptations due to technological obsolescence and other challenges. This article reflects on the positive impact that the recent ICH Q14 guidance can have on facilitating these changes. Five examples are provided that are based on scenarios in which analytical...
The International Council for Harmonisation (ICH) Q2(R2) and Q14 guidelines, finalized in late 2023, outline strategies for analytical procedure development, validation, and lifecycle management. As global implementation progresses, ISPE’s PQLI® Analytical Method Strategy Team surveyed industry stakeholders in mid-2024 to assess readiness, identify opportunities, and highlight areas...
In April 2023, ISPE launched a survey to understand the sources of barriers to technological innovation within the pharmaceutical industry. This survey is part of an expansive and significant initiative by ISPE, Enabling Global Pharma Innovation: Delivering for Patients, which aims to promote consistent and harmonized interpretation and implementation of guidelines issued by the International...
Defining requirements for calibration and routine testing of weighing equipment in the laboratory and production remains a complex endeavor for pharmaceutical companies. Applying sound, risk-based metrological strategies across the entire pharmaceutical value chain will help manufacturers ensure compliance, consumer safety, and commercial success.
The United States Pharmacopeia (USP) Packaging and Distribution Expert Committee approved chapters 665 and 1665 in 2024. These chapters establish clear and general guidelines for the use of plastic materials in process equipment used within the pharmaceutical and biotechnology industries. Their publication has raised new questions regarding the role of polymeric materials in manufacturing...
The increasing digitalization of the pharmaceutical and medical device industry has created novel cybersecurity challenges, particularly with the rapid advancement of artificial intelligence (AI) technologies. This article examines the dual nature of AI as both a potential threat vector and a powerful defensive tool.
The move to digital transformation represents a true paradigm shift in manufacturing, enabling organizations to leverage advanced technologies such as the Industrial Internet of Things (IIoT), cloud computing, and artificial intelligence (AI) to ensure compliance and secure a competitive advantage. This article presents a working definition of digital transformation, the components involved in...
Pharmaceutical companies can use digital maturity assessments to address the challenges of upgrading brownfield facilities and implementing digital transformation improvements. Enabled by stakeholder workshops, these assessments can rapidly produce concrete plans and priorities to guide a facility’s development over the next three to five years—delivering business value and laying the...
Pharma 4.0™ is a reference framework tailored to the pharmaceutical industry, guiding its digital transformation. Although many of today’s processes generate sufficient data to enable advanced use cases, structured guidance for transformation is often lacking. To address this, the ISPE Pharma 4.0™ Subcommittee on Process Data Maps and Critical Thinking has introduced an approach to help...
The often-overlooked function of chemistry, manufacturing, and controls (CMC) holds tremendous potential to reshape the landscape of drug development. By embracing innovation and rethinking traditional approaches, CMC has the rare opportunity to drive transformative changes that could significantly accelerate the journey from initial concept to a fully realized therapy. This offers the...
Currently, there is no single guidance document providing a comprehensive roadmap for executing digital validation. While elements from ISPE GAMP® Guides Series and the ISPE Baseline® Guide: Volume 8 – Pharma 4.0™, apply to digital validation, there is no consolidated resource addressing common questions. The authors of this Concept Paper therefore advocate for the development of a Good...
This article defines what constitutes a holistic control strategy in pharmaceutical development and manufacturing. It highlights the limitations of traditional, siloed approaches and demonstrates the added value of integrating these approaches across multiple dimensions. By identifying key gaps and proposing technological enablers, the article outlines a path toward a more comprehensive,...
In pharma, AI’s biggest challenge isn’t technical, it’s cultural.
2025 marks a significant milestone for the ISPE Argentina Affiliate with its 20th anniversary—commemorating two decades of commitment to excellence, collaboration, and integrity within the Latin American pharmaceutical community.
Laboratory automation in the pharmaceutical industry is rapidly evolving due to increasing regulatory demands and the need for efficiency, flexibility, and data integrity. However, fragmented systems, proprietary protocols, and inconsistent validation frameworks continue to limit progress.
The pharmaceutical industry is at a crossroads. Legacy systems, manual workflows, and paper-heavy processes are slowing down innovation.
P&ID walk-downs are a critical activity during commissioning and qualification (C&Q) turnover, ensuring that physical installations align with the design intent. Traditionally, this process relies on manual checks using printed drawings, which is labor-intensive and prone to human error. Although digital platforms exist across design, engineering, construction and turnover...
In 2020, CSL initiated a benchmarking activity with a small group of peer companies identified through ISPE to explore creation and maturation of Asset Management programs at each company. The initial sessions were a success, covering topics such as Asset Condition Evaluations and Asset Management Governance. CSL was keen to continue the conversations and gather more insights on certain...
ISPE has once again assembled the most comprehensive industry conference on aseptic manufacturing that all should attend. The planning committee began their efforts within days of last year’s outstanding conference, with this year’s building upon the learning of last year. The speakers at this year’s conference are shaping the future of aseptic processing and sterile manufacturing. The
Pharmaceutical companies have changed their operational model to meet the growing demand for complex biopharmaceuticals. These changes have allowed the pharmaceutical industry to deliver more than just the most efficient and sustainable solutions. Beyond efficiency, the pharmaceutical industry has begun leveraging advanced technologies to reshape the drug discovery and development process...
Two members of the International Society for Pharmaceutical Engineering (ISPE) participated in a recent workshop organized by the National Academies of Sciences, Engineering, and Medicine (NASEM). The event, titled Improving Resiliency in the U.S. Pharmaceutical Supply Chain Through Make-Buy-Invest Strategic Actions, was held on 22–23 October in Washington, D.C., USA, and via remote access....
On 20–21 October 2025, ISPE’s Enabling Pharmaceutical Innovation initiative team partnered with Brazil’s National Health Surveillance Agency (ANVISA) to host a workshop focused on innovation and regulatory harmonization in Latin America. The event aimed to explore opportunities for industry to work together with ANVISA and other health authorities to reduce obstacles and encourage innovative...
Laboratories are among the most resource-intensive environments, consuming large amounts of energy, water, and chemicals while providing much needed healthcare solutions to the community. It is important that an organization’s focus on go green initiatives trickles down all the way to how the laboratories handle their reagents, consumables, their instruments, laboratory process while...
Pharmaceutical manufacturing is at a turning point. For decades, large-scale centralized facilities have been the backbone of medicine production, but today’s healthcare landscape demands something different: flexibility and personalization. Patients need therapies that are accessible anywhere, tailored to individual needs, and produced with resiliency against shortages. Emerging models like...
On the final day of the 2025 ISPE Annual Meeting & Expo, regulators and senior industry leaders convened for the Global Regulatory Town Hall—a long-standing and popular feature of the annual event. The discussion focused on the growing impact of digitalization and the increasing use of artificial intelligence (AI) by both regulators and industry. The session featured a mix of pre-prepared...
The 2025 ISPE Pharma 4.0™ Conference will take place from 9–10 December in Barcelona, Spain, and virtually. In the video and transcript that follows, International Program Committee Member Alicia Tébar, General...
The 2025 ISPE International Honor Awards were hosted in Charlotte, North Carolina, USA at the 2025 ISPE Annual Meeting & Expo. Taking place during the Membership Meeting and Awards Lunch, the ceremony...
The 2025 ISPE Singapore Conference and Exhibition, hosted by the ISPE Singapore Affiliate, took place 27–29 August at Suntech Singapore. It is one of the largest and most well-regarded events for...
Insights from Maeve Treanor, ISPE Emerging Leader, Commissioning Qualification Verification (CQV) Engineer with No Deviation
The 2025 ISPE Pharma 4.0™ Conference is fast-approaching, taking place from 9–10 December in Barcelona, Spain, and virtually. In the videos and transcripts that follow, International Program Committee Members...
The 2025 ISPE Pharma 4.0™ Conference will take place 9–10 December in Barcelona, Spain, and virtually. In the videos and transcripts that follow, International Program Committee Member Line Lundsberg-Nielsen highlights several planned technical tracks and shares what she is most looking forward to at this year’s conference.
Technology transfer in pharmaceuticals has long relied on meticulous paper records and countless cross-checks to prove process equivalence between sites. Each move from pilot to commercial scale often felt like starting validation all over again.
Automation and robotics aren’t just futuristic concepts—they’re practical solutions reshaping how the pharmaceutical industry manufactures medicines. At this year’s Automation and Advanced Robotics track, which will be featured at the 2025 ISPE Pharma 4.0™ Conference, attendees will learn about case studies that show how...
Whether networking at events or collaborating through our Communities of Practice, the value of an ISPE membership is in the connections made between pharmaceutical industry professionals and Regulators to collaborate on solutions to common goals and challenges.
Are you a subject-matter expert in the global pharmaceutical industry? Are you brimming with knowledge about the latest technical developments or regulatory initiatives? Have you found an innovative solution to a real-world challenge?
Contribute your knowledge and experience to the always-evolving pharmaceutical industry!
Do you know someone whose profile or work should be featured in Pharmaceutical Engineering? Contact ISPE Publications Department.